C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CGC Canadian LP

Canopy Growth

NASDAQ · CGC

One of the original Canadian LPs. Formerly backed by Constellation Brands with US expansion through Acreage Holdings.

$0.93
-0.50%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
43/100 composite
Fundamentals58
Regulatory58
Market15
Editorial30
Composite · trailing 12 months

Canopy Growth earns a Neutral rating, with a 43 composite score and low 2/5 conviction. Fundamentals and regulatory quality jointly provide the strongest pillar contributions at 58 each, while market performance at 15 and editorial activity at 30 constrain the overall assessment. The fundamentals score reflects 9.6% year-over-year revenue growth, a 65.6 market-cap tier subscore, and a 63.2 cash-runway subscore. Regulatory support comes from an 80 jurisdiction posture and an 80 enforcement subscore. Those positives are offset by weak measured liquidity and limited newsroom activity, leaving the shares firmly inside the Neutral band rather than supporting a more constructive stance.

Licensed fundamentals data show revenue expanding 9.6% year over year, but profitability remains materially negative. Gross margin stands near 28%, while operating margin is negative 24.7%. A net loss of approximately $263 million and an EBITDA loss approaching $27 million confirm that sales growth has not translated into bottom-line improvement. The 6.1% cash-burn ratio contributes to the fundamentals score, although the financial condition remains stretched and the loss profile preserves liquidity and solvency risk. Primary regulatory filings show the latest filing dated June 15, 2026. Filing cadence remains a weak component at 25, with four events recorded over 180 days but none during the latest 90-day period. No enforcement hits support the stronger regulatory contribution. Institutional pricing feeds record no volume in the measured input, aligning with the 15 liquidity subscore, while CIN newsroom coverage records no newsroom or brief hits.

The principal forward catalyst rests with fundamentals: sustained revenue growth converting into better operating economics. The existing gross margin offers a base for leverage, but the negative operating margin and EBITDA result require measurable cost absorption before the 58 fundamentals pillar can drive an upgrade. Strong jurisdiction and enforcement scores provide regulatory stability, yet improved filing cadence alone cannot offset weak profitability, market liquidity, and editorial momentum. The single most important signal to watch is a clear narrowing of the operating-margin loss in the next primary regulatory filing.

Scored: 2026-09-19Valid through: 2026-11-03Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
1 HERSHEY DRIVE, SMITH FALLS, A6, K7A0A8
Phone
855-558-9333
CEO
Luc Mo***u
CFO
Thomas St***t
SEC CIK
1737927
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$435.5M
Enterprise value
$346.8M
Price to book
0.84
Price to sales
1.53
EV / EBITDA
11014.10
Revenue (TTM)
$284.6M
Gross profit (TTM)
$79.5M
EBITDA
$-26.8M
Operating margin
-24.7%
Profit margin
-92.4%
Rev growth YoY
9.6%
Return on equity
-44.7%
Return on assets
-3.9%
EPS (TTM)
$-0.62
EPS est. current year
$-0.47
Wall St. target price
$1.23
Shares outstanding
422.2M
Insider ownership
0.2%
Institutional ownership
7.9%
Beta
2.42
Full-time employees
1,128
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Canopy Growth (CGC)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Canopy Growth (CGC), a cannabis-sector equity listed on NASDAQ in the Canadian LP category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $1.58.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss, insider selling. (3 bullish signals, 4 bearish signals.)

One of the original Canadian LPs. Formerly backed by Constellation Brands with US expansion through Acreage Holdings.

Latest price: $0.93 (-0.50%) on NASDAQ.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CGC are maintained by Cannabis Investor News and refreshed throughout the trading day.